HDAC6 and ovarian carcinoma: The combination of a selective HDAC8 inhibitor PCI-34051 with a selective HDAC6 inhibitor citarinostat synergistically suppressed migration and induced apoptosis in p53 wild-type ovarian cancer cells [155].